https://millerlaboratory.org/clinical-trial/er-reactivation-therapy-for-breast-cancer-polly/2022-10-19T07:27:10-04:00https://millerlaboratory.org/clinical-trial/phase-ii-study-of-neoadjuvant-aromatase-inhibitor-therapy-for-er-breast-cancer-naomi/2022-10-19T07:27:57-04:00https://millerlaboratory.org/clinical-trial/developing-plasma-dna-as-a-surrogate-for-tumor-biopsy-to-identify-tumor-genetic-alterations-in-patients-with-advanced-breast-cancer/2022-10-20T09:41:20-04:00https://millerlaboratory.org/clinical-trial/phase-i-study-of-the-combination-of-mln9708-and-fulvestrant/2022-10-20T10:23:15-04:00https://millerlaboratory.org/clinical-trial/cancer-treatment-informed-by-the-molecular-tumor-board-at-dartmouth-catrina/2022-10-21T08:20:25-04:00https://millerlaboratory.org/clinical-trial/tumor-specific-plasma-dna/2022-10-21T08:22:22-04:00https://millerlaboratory.org/clinical-trial/presurgical-treatment-with-letrozole-in-patients-with-early-stage-breast-cancer/2022-10-21T08:28:58-04:00https://millerlaboratory.org/clinical-trial/early-phase-study-to-assess-inhibitor-ribociclib-in-patients-with-recurrent-glioblastoma-or-anaplastic-glioma/2022-10-21T08:39:26-04:00https://millerlaboratory.org/clinical-trial/estrogen-receptor-positive-breast-cancer-patient-derived-xenografts/2022-10-21T08:39:58-04:00https://millerlaboratory.org/clinical-trial/metformin-pharmacology-in-human-cancers-a-proof-of-principle-study/2022-10-21T08:40:14-04:00